Chirag Talati, pharma analyst, Espirito Santo Securities says the RBI's move to boost the Indian currency by asking exporters to convert 50% of their foreign exchange holdings into rupees will not have a significant impact on pharma companies.
first published: May 10, 2012 02:56 pm
A collection of the most-viewed Moneycontrol videos.

Nifty Clocks Second Week Of Gains But Still Awaits New Peak;Midcaps Snap 7-Week Run|Closing Bell

Will Nifty Bulls March Towards Fresh Peak Despite Dismal Global Cues? | Opening Bell Live

Nifty Aims For Next 26,100 After Hitting 3-Week High |Opening Bell Live

Nifty Back Above 26,000 As IT Stocks Sprint Ahead; Nvidia Earnings In Focus| Closing Bell Live
You are already a Moneycontrol Pro user.

